These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7555986)

  • 21. Vigabatrin as first add-on treatment in carbamazepine-resistant epilepsy patients.
    Murri L; Iudice A
    Acta Neurol Scand Suppl; 1995; 162():40-2. PubMed ID: 7495189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum concentrations and effects of gabapentin and vigabatrin: observations from a dose titration study.
    Lindberger M; Luhr O; Johannessen SI; Larsson S; Tomson T
    Ther Drug Monit; 2003 Aug; 25(4):457-62. PubMed ID: 12883229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study of vigabatrin vs. carbamazepine in monotherapy of newly diagnosed partial seizures in children.
    Sobaniec W; Kułak W; Strzelecka J; Smigielska-Kuzia J; Boćkowski L
    Pharmacol Rep; 2005; 57(5):646-53. PubMed ID: 16227648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-blind, placebo-controlled multicenter trial of vigabatrin in the treatment of epilepsy. The Italian Study Group on Vigabatrin.
    Ital J Neurol Sci; 1992 Dec; 13(9):741-7. PubMed ID: 1483856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials.
    Uthman BM; Almas M; Emir B; Giordano S; Leon T
    Curr Med Res Opin; 2011 Jul; 27(7):1285-93. PubMed ID: 21561392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group.
    Chadwick D
    Lancet; 1999 Jul; 354(9172):13-9. PubMed ID: 10406359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In children with refractory epilepsy: vigabatrin or lamotrigine?].
    Caviedes BE; Herranz JL; Arteaga R; Armijo JA
    Rev Neurol; 1999 Mar 1-15; 28(5):444-8. PubMed ID: 10229954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of antiepileptic drugs in the adjunctive treatment of refractory partial-onset seizures: Meta-analysis of pivotal trials.
    Slater J; Chung S; Huynh L; Duh MS; Gorin B; McMicken C; Ziemann A; Isojarvi J
    Epilepsy Res; 2018 Jul; 143():120-129. PubMed ID: 29784458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vigabatrin as add-on therapy for adult complex partial seizures: a double-blind, placebo-controlled multicentre study. The Canadian Vigabatrin Study Group.
    Bruni J; Guberman A; Vachon L; Desforges C
    Seizure; 2000 Apr; 9(3):224-32. PubMed ID: 10777431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New drugs in the treatment of childhood epilepsy: vigabatrin (study of 61 subjects)].
    Raucci U; Spalice A; Basile LA; Guardalà C; Nasta L; Terenzi S; Iannetti P
    Pediatr Med Chir; 1994; 16(6):575-8. PubMed ID: 7708543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Open label trial with vigabatrin in children with intractable epilepsy.
    Wong V
    Brain Dev; 1995; 17(4):249-52. PubMed ID: 7503385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Vigabatrin in the treatment of intractable focal epilepsy in children and adolescents. Two-year study].
    Kozik A; Ujma-Czapska B; Grotowska M
    Neurol Neurochir Pol; 2000; 34 Suppl 1():187-93. PubMed ID: 10768158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Once-daily versus twice-daily vigabatrin: is there a difference? The results of a double-blind pilot study.
    Zahner B; Stefan H; Blankenhorn V; Krämer G; Richens A; Thümler R; Mumford JP
    Epilepsia; 1999 Mar; 40(3):311-5. PubMed ID: 10080511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vigabatrin serum concentration to dosage ratio: influence of age and associated antiepileptic drugs.
    Armijo JA; Cuadrado A; Bravo J; Arteaga R
    Ther Drug Monit; 1997 Oct; 19(5):491-8. PubMed ID: 9357089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gamma-vinyl GABA (vigabatrin): relationship between dosage, plasma concentrations, platelet GABA-transaminase inhibition, and seizure reduction in epileptic children.
    Arteaga R; Herranz JL; Valdizán EM; Armijo JA
    Epilepsia; 1992; 33(5):923-31. PubMed ID: 1396437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vigabatrin and alterations of the visual field].
    Argumosa A; Herranz JL; Arteaga R; Barrasa J; Calles L; Armijo J
    Rev Neurol; 1999 Apr 16-30; 28(8):741-5. PubMed ID: 10363313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety, tolerability, and pharmacokinetics of pregabalin in children with refractory partial seizures: a phase 1, randomized controlled study.
    Mann D; Liu J; Chew ML; Bockbrader H; Alvey CW; Zegarac E; Pellock J; Pitman VW
    Epilepsia; 2014 Dec; 55(12):1934-43. PubMed ID: 25377429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vigabatrin in unsatisfactory controlled epilepsies. Swiss Vigabatrin Study Group.
    Russ W
    Schweiz Arch Neurol Psychiatr (1985); 1995; 146(2):55-9. PubMed ID: 7569836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vigabatrin vs. carbamazepine monotherapy in newly diagnosed focal epilepsy: a randomized response conditional cross-over study.
    Tanganelli P; Regesta G
    Epilepsy Res; 1996 Nov; 25(3):257-62. PubMed ID: 8956924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vigabatrin in uncontrolled seizures: Belgian clinical experience. The Belgian Vigabatrin Evaluation Group.
    Lhoir A
    Clin Neurol Neurosurg; 1994 Feb; 96(1):42-6. PubMed ID: 8187381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.